M

V

MONTESARCHIO , Vincenzo

Last name: MONTESARCHIO

First name: Vincenzo

2016 (v1)

Publication

Metadata-only

Resminostat in combination with sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER Study

Bitzer, Michael Horger, Marius GIANNINI, EDOARDO GIOVANNI

No established therapies for patients with hepatocellular carcinoma (HCC) and progression on first-line sorafenib treatment currently exist. This phase I/II trial investigated safety, pharmacokinetics (PK) and potential biomarkers of the deacetylase inhibitor (HDAC) resminostat and a combination therapy with resminostat and sorafenib.

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system

Riva, Silvia Arenare, Laura Di Maio, Massimo

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio

BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients.MethodsA multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of tocilizumab on lethality rates at 14 and 30 days...

Uploaded on: March 25, 2023